ESTA
Get informed when a big investor buys or sells
+ FollowOvervalued by 182.2% based on the discounted cash flow analysis.
| Market cap | $2.72 Billion |
|---|---|
| Enterprise Value | $2.66 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.72 |
| Beta | 1.07 |
| Outstanding Shares | 29,622,101 |
| P/E Ratio | -62.6 |
|---|---|
| PEG | 176.91 |
| Price to Sales | 13.52 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 11.59 |
| Enterprise Value to EBIT | -89.24 |
| Enterprise Value to Net Income | -61 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 59.95% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 1.57%▼ 88.79% |
|---|---|
| Total Invested | $39.95M▼ 97.37% |
| Investors Holding | 29▼ 160.00% |
No data
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...